Capital Investment Advisory Services’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Capital Investment Advisory Services’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000	Closed	–	–	1499
2019 Q1	$0	Hold	4,000	–	–	﹤0.01%	1319
2018 Q4	$0	Buy	+4,000	New	+$2.63K	﹤0.01%	1243

Capital Investment Advisory Services's SGYP Position: Q2 2019 in Review

Capital Investment Advisory Services sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 4,000 shares.

Capital Investment Advisory Services first reported a position in SGYP in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

Capital Investment Advisory Services reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
Capital Investment Advisory Services sold 4,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
Capital Investment Advisory Services first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2018 and held it in 2 quarters.
Capital Investment Advisory Services's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q1 2019.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on Capital Investment Advisory Services's 13F filing for Q2 2019, filed 8 Aug 2019.